{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:42:27Z","timestamp":1784158947099,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY024285"],"award-info":[{"award-number":["EY024285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI083214"],"award-info":[{"award-number":["AI083214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ajoc.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:56:08Z","timestamp":1536706568000},"page":"73-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Resolution of fluoroquinolone-resistant Escherichia coli keratitis with a PROSE device for enhanced targeted antibiotic delivery"],"prefix":"10.1016","volume":"12","author":[{"given":"Hualei","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J.M.","family":"Bispo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-4214","authenticated-orcid":false,"given":"Hidenaga","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2018.09.006_bib1","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkp255","article-title":"Has the era of untreatable infections arrived?","volume":"64","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajoc.2018.09.006_bib2","series-title":"Antibiotic Resistance Threats in the United States","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.ajoc.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajoc.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/ICL.0b013e318188e205","article-title":"Jupiter scleral lenses in the management of chronic graft versus host disease","volume":"34","author":"Schornack","year":"2008","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajoc.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bbmt.2007.05.006","article-title":"Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease","volume":"13","author":"Takahide","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajoc.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbmt.2015.07.027","article-title":"Use of prosthetic replacement of the ocular surface ecosystem scleral lenses in patients with ocular chronic graft-versus-host disease","volume":"21","author":"Theophanous","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajoc.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820530902802013","article-title":"The Boston Ocular Surface Prosthesis as a novel drug delivery system for bevacizumab","volume":"24","author":"Lim","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajoc.2018.09.006_bib8","series-title":"Performance Standards for Antimicrobial Suceptibility Testing Document M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.ajoc.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.2011.0072","article-title":"Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones","volume":"28","author":"Segreti","year":"2012","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.ajoc.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2009.07.037","article-title":"Clinical benefits of the Boston ocular surface prosthesis","volume":"149","author":"Stason","year":"2010","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618301798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618301798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:56:20Z","timestamp":1762527380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993618301798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":10,"alternative-id":["S2451993618301798"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.09.006","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolution of fluoroquinolone-resistant Escherichia coli keratitis with a PROSE device for enhanced targeted antibiotic delivery","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}